Sancuso and Dilaudid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sancuso (granisetron) and Dilaudid (hydromorphone hydrochloride). Common drug interactions include nausea among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Sancuso and Dilaudid. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Sancuso?

Sancuso has active ingredients of granisetron. eHealthMe is studying from 1,765 Sancuso users. Check the latest studies of Sancuso.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

21 people who take Sancuso and Dilaudid together, and have interactions are studied.

Sancuso and Dilaudid drug interactions.

What are the common drug interactions of Sancuso and Dilaudid, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Pancreatic carcinoma (pancreatic cancer)
  3. Pancreatitis (inflammation of pancreas)
  4. Red blood cell count decreased
  5. Vomiting
  6. White blood cell count decreased
  7. Abdominal pain
  8. Confusional state
  9. Cough
  10. Death

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Anaphylactic reaction (serious allergic reaction)
  3. Pneumonia
  4. Pruritus (severe itching of the skin)
  5. Urticaria (rash of round, red welts on the skin that itch intensely)
  6. Vomiting
  7. Brain neoplasm (tumour of brain)
  8. Death
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Diarrhoea

What are the common drug interactions of Sancuso and Dilaudid, by age (0-1 to 60+)? *:

0-1:

  1. Meningitis aseptic (a condition that causes the membranes covering your brain and spinal cord to become inflamed)

2-9:

n/a

10-19:

  1. Cough
  2. Nausea (feeling of having an urge to vomit)
  3. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  4. Tooth infection

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Brain neoplasm (tumour of brain)
  3. Confusional state
  4. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  5. Nausea (feeling of having an urge to vomit)
  6. Right ventricular failure (right half of the heart fails to work)
  7. Septic shock (shock due to blood infection)
  8. Skin wound
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Vomiting

40-49:

  1. Plasma cell myeloma (cancer that begins in plasma cells)

50-59:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Death
  3. Diarrhoea
  4. Lung disorder (lung disease)
  5. Lung neoplasm malignant (cancer tumour of lung)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Malignant neoplasm progression (cancer tumour came back)
  8. Metastases to bone (cancer spreads to bone)
  9. Nausea (feeling of having an urge to vomit)
  10. Platelet count decreased

60+:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Nausea (feeling of having an urge to vomit)
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Pneumonia
  5. Skin exfoliation (removal of the oldest dead skin cells)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 6 people, 28.57%
  2. Nausea (feeling of having an urge to vomit): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Sancuso and Dilaudid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sancuso and Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sancuso:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sancuso and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dilaudid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on granisetron and hydromorphone hydrochloride (the active ingredients of Sancuso and Dilaudid, respectively), and Sancuso and Dilaudid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: